RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...

Notable insider trades include ORESHACK KURT, General Counsel at Maravai Lifesciences Holdings Inc (MRVI), who sold 25000 shares on Jan 31 ’25, at $5.03 each, totaling $0.13 million. On May 28 ’24, ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).

We recently compiled a list of the 12 Stocks Under $5 With Biggest Upside Potential. In this article, we are going to take a look at where Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) stands ...

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

Maravai LifeSciences (NASDAQ:MRVI) said on Wednesday that based on preliminary year-end results, the company expects to report total 2024 revenue near the mid-point of the previously announced ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the target of some unusual options trading on ...

Maravai LifeSciences Holdings, Inc. announced that it expects total revenue for 2024 to align with its previous guidance range of $255 million to $265 million based on preliminary year-end results ...

SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...